Mesothelioma & Asbestos

Have you been diagnosed with pancreatic, colorectal or lung cancer after taking the weight-loss medication Belviq or Belviq XR?

You May Be Entitled To Compensation. 

FDA Recall on BELVIQ

Belviq® (lorcaserin hydrochloride) is a weight loss drug manufactured by Japanese drug maker Eisai originally approved for use by the FDA in 2012. Upon initial approval the FDA required Eisai to conduct a multiyear clinical trial to evaluate the risk of cardiovascular problems associated with Belviq® use. Risks of cancer also became a concern when a prevalence of tumors was observed in laboratory animals exposed to Belviq®.

Clinical Trial Results

Data collected from a five–year, 12,000 patient study of Belviq’s® potential negative cardiovascular side effects where half of the patients were given Belviq® and the other half given a placebo was reviewed by the FDA in January 2020. Outside of any cardiovascular side effects, the data showed a slightly greater occurrence of cancer diagnoses in the Belviq® patient sample set than in the placebo set (7.7% in patients who took Belviq® vs. 7.1% of patients who took the placebo). While a range of cancers were found in the sample, four cancers were found to occur disproportionately more than others in the Belivq® patients:

  • Pancreatic Cancer
  • Colon Cancer
  • Rectal Cancer
  • Lung Cancer

Based upon the findings, the FDA requested Eisai to voluntarily withdraw Belviq® and Belviq® XR (lorcaserin) from the market which they did in February 2020. At its peak, there were 600,000 prescriptions filled per year in the U.S. with no warning of potential increased risk of cancer. If you or someone you know may have a claim against Eisai, fill out the contact form below

Our Team

Our Team

Tropical Storm Nicholas could pose risk to insurance claims from Ida

September 16, 2021

by: Shannon Heckt Posted: Sep 14, 2021 / 09:00 AM CDT / Updated: Sep 14, 2021 / 09:44 AM CDT Source: https://wgno.com/news/louisiana/tropical-storm-n...

Read Full Article

Donelon orders insurers to pay evacuation expenses for Hurricane Ida

September 16, 2021

Staff Report Published 8:31 a.m. CT Sep 13, 2021 Source: https://www.postsouth.com/story/news/2021/09/13/insurance-commissioner-orders-insurers-pay-ev...

Read Full Article

Opioid Justice Team: Purdue’s Bankruptcy Plan Offers “Easy Pay” Option for OxyContin Users at the Expense of Babies Born Addicted to Opioids

September 16, 2021

Opioid Justice Team is comprised of attorneys fighting for children born dependent on opioids. Attorneys representing Purdue's adult victims stand to recei...

Read Full Article

Neonatal Abstinence Syndrome Ad Hoc Committee Objects To Sackler Funded Plan

September 16, 2021

In New Purdue Pharma Bankruptcy Filing, Lawyers for Children Born Dependent on Opioids Say Plan Unfairly Excludes the Youngest and Most Innocent Victims of...

Read Full Article

Rapides resident files lawsuit against Dresser facility after contamination found

September 16, 2021

(KKTV)    By Steven Maxwell      Published: May. 8, 2020 at 1:33 PM CDT Source: https://www.kalb.com/content/news/Rapid...

Read Full Article

Hard hat of missing Seacor Power crew member found along Texas coast: report

May 14, 2021

BY CATHERINE ZEILMAN | STAFF WRITER   PUBLISHED MAY 14, 2021 AT 12:47 PM | UPDATED MAY 14, 2021 AT 1:48 PM Source: Hard hat of missing Seacor Power crew m...

Read Full Article

© 2021 Martzell, Bickford & Centola. All Rights Reserved. | Sitemap | Developed By MediaSmack